Anpac Bio Medical Stock Operating Margin
| ANPCDelisted Stock | USD 4.37 0.20 4.38% |
Anpac Bio Medical fundamentals help investors to digest information that contributes to Anpac Bio's financial success or failures. It also enables traders to predict the movement of Anpac Stock. The fundamental analysis module provides a way to measure Anpac Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Anpac Bio stock.
Anpac |
Anpac Bio Medical Company Operating Margin Analysis
Anpac Bio's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Anpac Bio Operating Margin | (8.71) % |
Most of Anpac Bio's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Anpac Bio Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
CompetitionBased on the recorded statements, Anpac Bio Medical has an Operating Margin of -8.7113%. This is 75.17% lower than that of the Healthcare sector and 92.23% lower than that of the Biotechnology industry. The operating margin for all United States stocks is 58.1% higher than that of the company.
Anpac Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Anpac Bio's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Anpac Bio could also be used in its relative valuation, which is a method of valuing Anpac Bio by comparing valuation metrics of similar companies.Anpac Bio is currently under evaluation in operating margin category among its peers.
Anpac Fundamentals
| Return On Equity | -2.43 | |||
| Return On Asset | -0.53 | |||
| Operating Margin | (8.71) % | |||
| Current Valuation | 9.28 M | |||
| Shares Outstanding | 6.27 M | |||
| Shares Owned By Insiders | 2.15 % | |||
| Shares Owned By Institutions | 0.09 % | |||
| Number Of Shares Shorted | 44.48 K | |||
| Price To Book | 5.67 X | |||
| Price To Sales | 0.41 X | |||
| Revenue | 12.04 M | |||
| Gross Profit | 12.25 M | |||
| EBITDA | (78.4 M) | |||
| Net Income | (103.6 M) | |||
| Cash And Equivalents | 462 K | |||
| Cash Per Share | 0.02 X | |||
| Total Debt | 19.81 M | |||
| Debt To Equity | 1.44 % | |||
| Current Ratio | 0.39 X | |||
| Book Value Per Share | 10.63 X | |||
| Cash Flow From Operations | (55.06 M) | |||
| Short Ratio | 2.50 X | |||
| Earnings Per Share | (11.45) X | |||
| Target Price | 8.0 | |||
| Beta | 1.56 | |||
| Market Capitalization | 27.41 M | |||
| Total Asset | 40.47 M | |||
| Retained Earnings | (577.54 M) | |||
| Working Capital | (28.58 M) | |||
| Current Asset | 23.44 M | |||
| Current Liabilities | 68.22 M | |||
| Z Score | -26.09 | |||
| Net Asset | 40.47 M |
About Anpac Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Anpac Bio Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Anpac Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Anpac Bio Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Consideration for investing in Anpac Stock
If you are still planning to invest in Anpac Bio Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Anpac Bio's history and understand the potential risks before investing.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |